Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study

 

Show simple item record

dc.contributor.author Allen, Elizabeth N
dc.contributor.author Gomes, Melba
dc.contributor.author Yevoo, Lucy
dc.contributor.author Egesah, Omar
dc.contributor.author Clerk, Christine
dc.contributor.author Byamugisha, Josaphat
dc.contributor.author Mbonye, Anthony
dc.contributor.author Were, Edwin
dc.contributor.author Mehta, Ushma
dc.contributor.author Atuyambe, Lynn M
dc.date.accessioned 2015-01-21T13:30:07Z
dc.date.available 2015-01-21T13:30:07Z
dc.date.issued 2014-10-31
dc.identifier.citation Allen et al.: Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study. BMC Health Services Research. 2014 Oct 31;14(1):525 en_ZA
dc.identifier.issn 1472-6963 en_ZA
dc.identifier.uri http://dx.doi.org/10.1186/s12913-014-0525-1
dc.identifier.uri http://hdl.handle.net/11427/12288
dc.identifier.uri http://hdl.handle.net/11427/12288
dc.identifier.uri http://dx.doi.org/10.1186/s12913-014-0525-1
dc.description.abstract Background: The World Health Organisation has designed a pregnancy registry to investigate the effect of maternal drug use on pregnancy outcomes in resource-limited settings. In this sentinel surveillance system, detailed health and drug use data are prospectively collected from the first antenatal clinic visit until delivery. Over and above other clinical records, the registry relies on accurate participant reports about the drugs they use. Qualitative methods were incorporated into a pilot registry study during 2010 and 2011 to examine barriers to women reporting these drugs and other exposures at antenatal clinics, and how they might be overcome. Methods: Twenty-seven focus group discussions were conducted in Ghana, Kenya and Uganda with a total of 208 women either enrolled in the registry or from its source communities. A question guide was designed to uncover the types of exposure data under- or inaccurately reported at antenatal clinics, the underlying reasons, and how women prefer to be asked questions. Transcripts were analysed thematically. Results: Women said it was important for them to report everything they had used during pregnancy. However, they expressed reservations about revealing their consumption of traditional, over-the-counter medicines and alcohol to antenatal staff because of anticipated negative reactions. Some enrolled participants' improved relationship with registry staff facilitated information sharing and the registry tools helped overcome problems with recall and naming of medicines. Decisions about where women sought care, which influenced medicines used and antenatal clinic attendance, were influenced by pressure within and outside of the formal healthcare system to conform to conflicting behaviours. Conversations also reflected women's responsibilities for producing a healthy baby. Conclusions: Women in this study commonly take traditional medicines in pregnancy, and to a lesser extent over-the-counter medicines and alcohol. The World Health Organisation pregnancy registry shows potential to enhance their reporting of these substances at the antenatal clinic. However, more work is needed to find optimal techniques for eliciting accurate reports, especially where the detail of constituents may never be known. It will also be important to find ways of sustaining such drug exposure surveillance systems in busy antenatal clinics. en_ZA
dc.language eng en_ZA
dc.publisher BioMed Central en_ZA
dc.rights Creative Commons Attribution 4.0 International (CC BY 4.0) *
dc.rights.uri http://creativecommons.org/licenses/by/4.0/ en_ZA
dc.source BMC Health Services Research en_ZA
dc.source.uri http://www.biomedcentral.com/1472-6963
dc.title Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study en_ZA
dc.type Journal Article en_ZA
dc.date.updated 2015-01-15T17:54:50Z
dc.language.rfc3066 en
dc.rights.holder Allen et al.; licensee BioMed Central Ltd.
uct.type.publication Research en_ZA
uct.type.resource Article en_ZA
dc.publisher.institution University of Cape Town
dc.publisher.faculty Faculty of Health Sciences en_ZA
dc.publisher.department Division of Clinical Pharmacology en_ZA
uct.type.filetype
uct.type.filetype Text
uct.type.filetype Image


Files in this item

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International (CC BY 4.0) Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International (CC BY 4.0)